The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Aktina Medical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Aktina Medical is a medical device company that specializes in the design, development, and manufacturing of radiation therapy and oncology systems. The company’s product portfolio includes elekta small field circular cones, body radiosurgery, head and neck, pinpoint radiosurgery, breast treatment, thermoplastics, graticules & reticules, phantoms, beam shaping, and others. It offers radiation therapy, nuclear medicine, diagnostic imaging and medical health physics. The company also offers shielding design services, linac commissioning and clinical implementation services, remote radiosurgery treatment planning services, dosimetry staffing and others. Aktina Medical is headquartered in North Congers, New York, the US.
The key metrics of Aktina Medical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Aktina Medical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Aktina Medical.
For a detailed understanding of the performance of Aktina Medical, buy the report here.